社论：包括 SARS-CoV-2（JN.1）、流感、呼吸道合胞病毒（RSV）和麻疹在内的疫苗可预防感染的全球健康问题持续上升。
Editorial: Global Health Concerns as Vaccine-Preventable Infections Including SARS-CoV-2 (JN.1), Influenza, Respiratory Syncytial Virus (RSV), and Measles Continue to Rise.
机构信息
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA.
出版信息
Med Sci Monit. 2024 Feb 1;30:e943911. doi: 10.12659/MSM.943911.
Abstract
In December 2023, the US Centers for Disease Control and Prevention (CDC) published the updated 2024 Advisory Committee on Immunization Practices (ACIP) Adult Immunization Schedule, which is available online for access by the public and healthcare professionals. These new guidelines come at a time when the incidence of vaccine-preventable viral infections from SARS-CoV-2 (JN.1), respiratory syncytial virus (RSV), influenza, and measles are increasing in adults and children due to vaccine hesitancy, or non-compliance. This editorial aims to highlight the ongoing global health concerns for the consequences of increasing reports of vaccine-preventable infections, including SARS-CoV-2 (JN.1), influenza, RSV, and measles, to understand the causes of vaccine hesitancy, and introduce some public health measures that could improve vaccine uptake.
摘要
2023 年 12 月，美国疾病控制与预防中心（CDC）发布了更新的 2024 年免疫实践咨询委员会（ACIP）成人免疫接种时间表，供公众和医疗保健专业人员在线访问。这些新指南发布之际，由于疫苗犹豫或不遵守规定，导致 SARS-CoV-2（JN.1）、呼吸道合胞病毒（RSV）、流感和麻疹等可通过疫苗预防的病毒感染在成人和儿童中的发病率不断上升。本社论旨在强调不断增加的可通过疫苗预防的感染（包括 SARS-CoV-2（JN.1）、流感、RSV 和麻疹）报告所带来的全球健康问题，了解疫苗犹豫的原因，并介绍一些可能提高疫苗接种率的公共卫生措施。
相似文献
1
Editorial: Global Health Concerns as Vaccine-Preventable Infections Including SARS-CoV-2 (JN.1), Influenza, Respiratory Syncytial Virus (RSV), and Measles Continue to Rise.
Med Sci Monit. 2024 Feb 1;30:e943911. doi: 10.12659/MSM.943911.
2
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840.
3
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.
4
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Oct 6;54(10):1035-1059. doi: 10.3760/cma.j.cn112150-20200911-01198.
5
Vaccine hesitancy among people with multiple sclerosis.
Mult Scler Relat Disord. 2021 Nov;56:103236. doi: 10.1016/j.msard.2021.103236. Epub 2021 Sep 2.
6
Characteristics and outcomes of patients hospitalized for infection with influenza, SARS-CoV-2 or respiratory syncytial virus in the season 2022/2023 in a large German primary care centre.
Eur J Med Res. 2023 Dec 6;28(1):568. doi: 10.1186/s40001-023-01482-z.
7
Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.
8
[Technical guidelines for seasonal influenza vaccination in China (2023-2024)].
Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Oct 10;44(10):1507-1530. doi: 10.3760/cma.j.cn112338-20230908-00139.
9
A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022.
J Med Virol. 2022 Dec;94(12):5802-5807. doi: 10.1002/jmv.28065. Epub 2022 Aug 23.
10
Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020.
Euro Surveill. 2021 Jul;26(29). doi: 10.2807/1560-7917.ES.2021.26.29.2001600.
引用本文的文献
1
Vaccine fatigue and influenza vaccination trends across Pre-, Peri-, and Post-COVID-19 periods in the United States using epic's cosmos database.
PLoS One. 2025 Jun 17;20(6):e0326098. doi: 10.1371/journal.pone.0326098. eCollection 2025.
2
Editorial: Surveillance of Seasonal Respiratory Syncytial Virus (RSV) Infection in Children and Vulnerable Adults Drives Vaccine Development and New Immunization Programs.
Med Sci Monit. 2025 May 1;31:e949558. doi: 10.12659/MSM.949558.
3
Evaluation of the Content Validity of the COVID-19 Symptoms Daily Diary.
Patient Relat Outcome Meas. 2025 Jan 17;16:37-53. doi: 10.2147/PROM.S488914. eCollection 2025.
4
Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review.
Infect Dis Ther. 2025 Jan;14(Suppl 1):5-37. doi: 10.1007/s40121-024-01080-4. Epub 2024 Dec 30.
5
Raising Epidemiological Awareness: Assessment of Measles/MMR Susceptibility in Highly Vaccinated Clusters within the Hungarian and Croatian Population-A Sero-Surveillance Analysis.
Vaccines (Basel). 2024 May 1;12(5):486. doi: 10.3390/vaccines12050486.
6
A Review of the Resurgence of Measles, a Vaccine-Preventable Disease, as Current Concerns Contrast with Past Hopes for Measles Elimination.
Med Sci Monit. 2024 Mar 13;30:e944436. doi: 10.12659/MSM.944436.
本文引用的文献
1
As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest".
JAMA. 2024 Feb 6;331(5):382-383. doi: 10.1001/jama.2023.27841.
2
Is Vaccination Approaching a Dangerous Tipping Point?
JAMA. 2024 Jan 23;331(4):283-284. doi: 10.1001/jama.2023.27685.
3
Covid-19: WHO adds JN.1 as new variant of interest.
BMJ. 2023 Dec 21;383:2975. doi: 10.1136/bmj.p2975.
4
Divergent Attitudes Toward COVID-19 Vaccine vs Influenza Vaccine.
JAMA Netw Open. 2023 Dec 1;6(12):e2349881. doi: 10.1001/jamanetworkopen.2023.49881.
5
Editorial: Outbreaks of Post-Pandemic Childhood Pneumonia and the Re-Emergence of Endemic Respiratory Infections.
Med Sci Monit. 2023 Dec 1;29:e943312. doi: 10.12659/MSM.943312.
6
Outlook of pandemic preparedness in a post-COVID-19 world.
NPJ Vaccines. 2023 Nov 20;8(1):178. doi: 10.1038/s41541-023-00773-0.
7
Unveiling the Impact of COVID-19 Vaccines: A Meta-Analysis of Survival Rates Among Patients in the United States Based on Vaccination Status.
Cureus. 2023 Aug 10;15(8):e43282. doi: 10.7759/cureus.43282. eCollection 2023 Aug.
8
Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2.
Med Sci Monit. 2023 Sep 1;29:e942244. doi: 10.12659/MSM.942244.
9
Revamping Public Health Systems: Lessons Learned From the Tripledemic.
Am J Prev Med. 2024 Jan;66(1):185-188. doi: 10.1016/j.amepre.2023.08.013. Epub 2023 Aug 18.
10
Why Parents Say No to Having Their Children Vaccinated against Measles: A Systematic Review of the Social Determinants of Parental Perceptions on MMR Vaccine Hesitancy.
Vaccines (Basel). 2023 May 2;11(5):926. doi: 10.3390/vaccines11050926.
Zotero 插件